Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries.
Parasite dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) are known target enzymes of antifolate drugs used for the treatment and prophylaxis of persons with malaria. We sequenced the Plasmodium vivax dihydrofolate reductase (pvdhfr) and dihydropteroate synthase (pvdhps) genes to examine the prevalence and extent of point mutations in isolates from malaria-endemic countries. Double mutations (S58R and S117N) or quadruple mutations (F57L/I, S58R, T61M, and S117T) in the pvdhfr gene were found in isolates from Thailand (96.4%) and Myanmar (71.4%), but in only one isolate (1.0%) from Korea, where sulfadoxine-pyrimethamine has never been used. The pvdhfr point mutations correlated strongly with the pvdhps point mutations and ranged from single to triple mutations (S382A, A383G, and A553G), among isolates from Thailand, Myanmar, and Korea. These findings suggests that the prevalence of mutations in pvdhfr and pvdhps in P. vivax isolates from different malaria-endemic countries is associated with selection pressure imposed by sulfadoxine-pyrimethamine.
Lu
Feng
F
Department of Parasitology, Kangwon National University College of Medicine, Chuncheon, Republic of Korea. lufeng981@hotmail.com
Lim
Chae Seung
CS
Nam
Deok Hwa
DH
Kim
Kwonkee
K
Lin
Khin
K
Kim
Tong-Soo
TS
Lee
Hyeong-Woo
HW
Chen
Jun-Hu
JH
Wang
Yue
Y
Sattabongkot
Jetsumon
J
Han
Eun-Taek
ET
D000483:Alleles; D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D004094:Dihydropteroate Synthase / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics*; D019353:Endemic Diseases; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006801:Humans; D016780:Malaria, Vivax / Q000453:epidemiology*; D009154:Mutation; D010966:Plasmodium vivax / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D016133:Polymerase Chain Reaction; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics*
D017931:DNA Primers; D005493:Folic Acid Antagonists; D013762:Tetrahydrofolate Dehydrogenase; D004094:Dihydropteroate Synthase
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):97-106
11425182
Antimicrob Agents Chemother. 2003 May;47(5):1514-21
12709316
Am J Trop Med Hyg. 2008 Mar;78(3):462-7
18337344
Acta Trop. 2010 Feb;113(2):105-13
19835832
Antimicrob Agents Chemother. 2002 Dec;46(12):3947-53
12435700
Trends Parasitol. 2007 May;23(5):213-22
17368986
Antimicrob Agents Chemother. 2004 Jun;48(6):2214-22
15155224
J Infect Dis. 2008 Aug 1;198(3):409-17
18582193
Antimicrob Agents Chemother. 2004 Jul;48(7):2581-7
15215112
Am J Trop Med Hyg. 1995 Jun;52(6):565-8
7611566
Am J Trop Med Hyg. 2006 Oct;75(4):617-21
17038682
Lancet Infect Dis. 2009 Sep;9(9):555-66
19695492
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7149-53
8041761
Parasitol Res. 2005 Jul;96(5):321-5
15924223
Bull World Health Organ. 2006 Oct;84(10):827-34
17128363
EMBO J. 1998 Jul 15;17(14):3807-15
9669998
Am J Trop Med Hyg. 2009 Aug;81(2):348-55
19635897
Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):468-72
9373658
Mol Biochem Parasitol. 1998 May 1;92(2):265-73
9657331
Am J Trop Med Hyg. 2009 Feb;80(2):215-7
19190216
Trop Med Int Health. 2004 Nov;9(11):1184-90
15548314
Mol Biochem Parasitol. 2002 Jan;119(1):63-73
11755187
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2009 Apr;27(2):175-6
19856512
Trends Parasitol. 2001 Dec;17(12):582-8
11756042
Emerg Infect Dis. 2001 Jan-Feb;7(1):35-42
11266292
Antimicrob Agents Chemother. 2008 Jul;52(7):2657-9
18443118
Drug Resist Updat. 1999 Feb;2(1):15-19
11504465
Antimicrob Agents Chemother. 2005 Oct;49(10):4393-5
16189131
Acta Trop. 2006 May;98(2):196-9
16647679
Trop Med Int Health. 2008 Jan;13(1):91-8
18291007
Bull World Health Organ. 1959;20(1):27-36
13638787
Am J Trop Med Hyg. 2007 Jun;76(6):1057-65
17556611
Am J Trop Med Hyg. 2003 Sep;69(3):247-52
14628939